Adenocarcinoma of lung (disorder)
|
0.030 |
Biomarker
|
disease |
BEFREE |
The lung adenocarcinoma (LUAD) cell line A549 was transduced with lentiviral packaging vectors overexpressing either wild-type ABCE1 or ABCE1 with Fe-S cluster deletions (ΔABCE1).
|
29145194 |
2017 |
Adenocarcinoma of lung (disorder)
|
0.030 |
Biomarker
|
disease |
BEFREE |
Our results demonstrated the potential role of ABCE1 in human lung adenocarcinoma, which may provide some molecular basis for the mechanisms of development and progress of human lung adenocarcinoma, and help to find new pharmacological targets.
|
22267055 |
2012 |
Adenocarcinoma of lung (disorder)
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of ABCE1 in the LTEP‑a-2 lung adenocarcinoma cell line was achieved by transfection with a plasmid containing full‑length ABCE1 cDNA.
|
27314749 |
2016 |
Adult Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.
|
25072059 |
2015 |
Breast Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
We previously demonstrated that miR-96 has a suppressive effect on breast cancer aggressiveness and that this effect was mediated by ABCE1 gene regulation.
|
31007850 |
2019 |
Breast Carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Finally, it was concluded that PLZF expression caused an ABCE1-mediated increase in cellular cytotoxicity, as demonstrated by a reduction in the proliferation rate of breast cancer cell lines.
|
30214553 |
2018 |
Breast Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Human data analysis further strengthened miR-96/ABCE1 role in breast cancer tumor aggression.
|
30305609 |
2018 |
Breast Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Furthermore, ABCE1‑siRNA was found to inhibit proliferation and invasion in breast cancer cells, significantly induce breast cancer cell apoptosis (P<0.05) in vitro and increase the protein expression of RNase L. These findings showed that ABCE1 had an important role in proliferation, invasion and apoptosis in MCF‑7 human breast cancer cells and that ABCE1 may inhibit intracellular RNase L activity, which inhibits the 2‑5A/RNase L pathway, interfering with the biological characteristics of breast cancer cells.
|
25070080 |
2014 |
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Recent evidence has shown the new roles of ABCE1 in tumorigenesis.
|
30455394 |
2018 |
Carcinogenesis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
What's more, miR-153 over-expression inhibited tumorigenesis and ABCE1 expression, while increased miR-153 level in tumor tissues.
|
31306106 |
2019 |
Carcinoma of lung
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Taken together, these data suggest that overexpression of ABCE1 produces an obvious effect on the motility of lung cancer cells through cytoskeleton rearrangement.
|
27109616 |
2016 |
Carcinoma of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
In conclusion, the present study suggested that ABCE1 promotes the growth, invasion and metastasis of lung adenocarcinoma cells and may represent a potential biomarker and therapeutic target for lung cancer.
|
27314749 |
2016 |
Carcinoma of lung
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Moreover, the impairment of RNase L in lung cancer cells was due to the elevated expression of RLI.
|
31501431 |
2019 |
Carcinoma of lung
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Studies in lung cancer have shown that overexpression of ABCE1 in tumor cells promotes growth and inhibits apoptosis.
|
25070080 |
2014 |
Carcinoma of lung
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The expression levels of Tip60 and ABCE1 acetylation were examined using western blot and co-immunoprecipitation (Co-IP) assays in normal bronchial epithelial (HBE) and human lung cancer (A549) cells.
|
30936993 |
2019 |
Carcinoma of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
These findings indicate that ABCE1 is involved in the development and progression of lung cancer through the CCL7 signaling pathway.
|
30214518 |
2018 |
Carcinoma of lung
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
MiR-153 inhibits the resistance of lung cancer to gefitinib via modulating expression of ABCE1.
|
31306106 |
2019 |
Carcinoma of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, the disordered decreased of miR-299-3p and resulting ABCE1 up-expression may contribute to chemoresistance of lung cancer, and miR-299-3p-ABCE1 may represent a new potential therapeutic target for the treatment of chemoresistance of lung cancer.
|
26617714 |
2015 |
Carcinoma of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
This work aimed to investigate the alterations in chemosensitivity of A549 lung cancer cells for 5-Fluorouracil (5-FU) and irinotecan by silencing ABCE1 using specific small interfering RNAs (siRNA).
|
25744244 |
2015 |
Carcinoma of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
We have previously shown that ABCE1 is a prognostic indicator for lung cancer, although the underlying mechanisms remain unclear.
|
26733164 |
2016 |
Carcinoma of lung
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Fe-S clusters of ABCE1 may be potential targets for the prevention of lung cancer metastasis.
|
29145194 |
2017 |
Childhood Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.
|
25072059 |
2015 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that the ABCE1 and its peptides could be target molecules in specific immunotherapy for HLA-A2(+) colon cancer patients.
|
15809757 |
2005 |
Colonic Neoplasms
|
0.010 |
Biomarker
|
group |
LHGDN |
ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients.
|
15809757 |
2005 |
Colorectal Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
The role of ABC transporters in progression and clinical outcome of colorectal cancer.
|
22294766 |
2012 |